{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-008825","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.430730+00:00","generated_at":"2026-06-06T13:53:25.268178+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HOOKIPA Pharma transfers listing to Nasdaq Capital Market to regain bid price compliance","bullets":["Received Nasdaq approval to transfer common stock listing from Global Select Market to Capital Market effective Feb 1, 2024.","Granted a second 180-day compliance period until July 29, 2024 to meet $1.00 minimum bid price requirement.","Company must close at $1.00 per share for 10 consecutive business days to regain compliance.","If compliance not achieved by July 29, 2024, Nasdaq may delist the stock; Company may appeal.","Company intends to cure deficiency via a reverse stock split if necessary."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-008825","json":"https://secwatch.observer/filing/0001104659-24-008825.json","markdown":"https://secwatch.observer/filing/0001104659-24-008825.md","text":"https://secwatch.observer/filing/0001104659-24-008825.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/0001104659-24-008825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/tm244750d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:53:25.268178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9d897beaf1b0682dc292e9b1b6cf305cf4456cc","claim":"HOOKIPA Pharma Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"from The Nasdaq Global Select Market tier to The Nasdaq Capital Market tier, as well as the Company’s request for a second 180-calendar day period, or until July 29, 2024 (the “Second Compliance Period”), to regain compliance with the $1.00 bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2). To regain compliance with such minimum price requirement, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The transfer of the listing of the Company’s Common Stock from The Nasdaq Global Select Market to The Nasdaq","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/0001104659-24-008825-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}